Newapproaches based on CypA are currently being developed for the treatment oflimb ischemia, neutralization of the side effects of Cyclosporine A (CsA)therapy, etc. However, the role of CypA in the antitumor immune response isstill unexplored. Here, PPIA is linked to ischemia.